President, National Academy of Medicine
Victor Dzau is president of the National Academy of Medicine, where he has launched the Grand Challenge on Health Longevity. Prior to 2014, when he began his six-year term, Dzau served as chancellor for health affairs and president and CEO of Duke University Health System, and as chairman of medicine at both Stanford and Harvard. His research laid the foundation for angiotensin-converting-enzyme inhibitors, used to treat high blood pressure and congestive heart failure. He pioneered gene therapy for vascular disease and was the first to introduce DNA decoy molecules as gene therapy in humans. Dzau has chaired the National Institutes of Health Cardiovascular Disease Advisory Committee, among other service.